Showing 7211-7220 of 9737 results for "".
- Olympic Swimmer Dara Torres Named Brand Ambassador for AmLactinhttps://practicaldermatology.com/news/20120329-olympic_swimmer_dara_torres_named_brand_ambassador_for_amlactin/2459830/AmLactin Alpha-Hydroxy Skin Care is kicking off the new “Ultra Skin Performance” campaign (Upsher-Smith Laboratories, Inc.) and has named 12-time Olympic medalist Dara Torres its first-ever brand ambassador . The “Ultra Skin Performance” campaign educates women of all ages about the internal and ext
- Medical Students Not Concerned About Skin Cancershttps://practicaldermatology.com/news/20120326-medical_students_not_concerned_about_skin_cancers/2459831/Medical students understand the causes of skin cancer but may be confused about SPF and sunscreen use, comments in recent focus groups suggest. (Arch Dermatol. 148(3):392-393) Surprisingly, most medical students
- La Roche-Posay Launches Mobile “Dermatologist By Your Side” Educationhttps://practicaldermatology.com/news/20120320-la_roche-posay_launches_mobile_dermatologist_by_your_side_education/2459835/When patients want advice on skin care products in the pharmacy or anywhere, they can dial **DERM from a mobile phone. An automated text response leads them to a dedicated YouTube.com site, featuring educational videos from dermatologists Kavita Mariwala, MD and Shirley Chi, MD. The program from
- Skinvisible Granted Patent for UVA Absorberhttps://practicaldermatology.com/news/20120320-skinvisible_granted_patent_for_uva_absorber/2459836/Skinvisible Pharmaceuticals, Inc. has been granted a new patent for its UVA sunscreen absorber. Skinvisible's new formulation with avobenzone provides eight hours of photostability, an advantage for those who spend many hours in the sun. The ingredi
- EHR iPad App Now Features Speech Recognitionhttps://practicaldermatology.com/news/20120320-ehr_ipad_app_now_features_speech_recognition/2459838/The EZ DERM EHR iPad app is now powered by the cloud-based Nuance Healthcare 360 | Development Platform. The speech recognition platform provides CPU intensive speech and
- Galderma Completes Phase 3 Rosacea Erythema Studyhttps://practicaldermatology.com/news/20120320-galderma_completes_of_phase_3_rosacea_erythema_study/2459839/Galderma Laboratories announced the completion of two independent Phase 3 clinical trials that evaluated the safety and efficacy of CD07805/47, a proprietary topical gel under investigation in patients with moderate to severe facial erythema of
- DUSA Launches “Spot the Signs of AK” Campaignhttps://practicaldermatology.com/news/20120320-dusa_launches_spot_the_signs_of_ak_campaign/2459840/DUSA Pharmaceuticals, Inc. introduced a new campaign called “Spot the Signs of AK” to boost awareness for actinic keratosis. The goal of the campaign is to inform the public about the dangers of cumulative sun damage and how it can cause AKs.
- Phase 3 Trials launching for adalimumab for hidradenitis suppurativahttps://practicaldermatology.com/news/20120315-phase_3_trials_launching_for_adalimumab_for_hidradenitis_suppurativa/2459842/Two Phase 3 clinical trials are underway to evaluate the safety and efficacy of Abbott's Humira (adalimumab) in adult patients with moderate to severe hidradenitis suppurativa (HS). The
- Merz Clarifies Status of Xeomin, Appoints William (Bill) Humphries CEOhttps://practicaldermatology.com/news/20120314-merz_clarifies_status_of_xeomin_appoints_new_ceo/2459845/Following a hearing in US District Court yesterday, Merz, Inc. is clarifying the availability of Xeomin and has appointed William (Bill) D. Humphries as CEO of Merz Inc., effective March 15. Merz Pharmaceuticals, LLC will continue to sell Xeomin fo
- Syneron to Acquire TransPharma Medicalhttps://practicaldermatology.com/news/20120313-syneron_to_acquire_transpharma_medical/2459847/Syneron Medical Ltd. (NASDAQ: ELOS) has signed a definitive agreement to acquire substantially all the assets of TransPharma Medical Ltd. TransPharma Medical, a specialty pharmaceutical company focused on the development and commercialization of drug-